Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 14 to 50

Using PRP injections to improve recovery after ACL surgery

Official title: Platelet Rich Plasma (PRP) Treatment of the Anterior Cruciate Ligament Injured Knee to Decrease the Risk of Post-traumatic Osteoarthritis (PTOA): a Randomized Double-blind Controlled Trial

Run by Hospital for Special Surgery, New York · NCT05412381 · Data updated 2026-11-12

This study tests if PRP injections can help people recover better and reduce inflammation after ACL surgery compared to a placebo.

Quick facts

PhasePhase 3
Study typeInterventional
Ages14 Years to 50 Years
SexAll
Enrollment56 (estimated)
SponsorHospital for Special Surgery, New York
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJune 27, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 13, 2026
Trial IDNCT05412381 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 14-50 who have sustained an acute ACL injury within the last 6 weeks.

Probably not a fit

Patients with prior ACL reconstruction, significant cartilage lesions, or other ligament injuries requiring repair may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of platelet-rich plasma (PRP) injections on reducing inflammation and improving joint function in patients who have suffered acute anterior cruciate ligament (ACL) injuries. The study involves a randomized controlled trial design, comparing PRP injections to placebo saline injections in patients undergoing ACL reconstruction. It aims to assess the short-term outcomes related to inflammation biomarkers and functional recovery, addressing the common issue of post-traumatic osteoarthritis that can develop after ACL injuries. The trial is powered based on the KOOS Jr. questionnaire, focusing on the functional outcomes of the participants.

Why it matters

Potential benefit: If successful, this approach could significantly enhance recovery and reduce the risk of developing post-traumatic osteoarthritis in patients with ACL injuries.

How similar studies have gone: Other studies have shown promising results with PRP injections in similar contexts, suggesting potential benefits in recovery and inflammation management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Acute ACL injury within 6 weeks of presentation
* Age 14-50
* Male or female
* Meniscus injury that can be treated with meniscectomy or repair (the lack of meniscus injury will not exclude patients)

Exclusion Criteria:

* Prior ACL reconstruction
* Prior cartilage repair procedure
* Prior meniscus surgery within 12 months
* Prior steroid, hyaluronic acid, or PRP injection within 6 months
* Other ligament injury requiring repair
* Any cartilage lesion requiring repair
* Any cartilage lesion greater than grade 2 (partial thickness injury)
* History of inflammatory arthritis or joint sepsis
* Non English speakers

Where it's running

  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Gait rehabilitation using biofeedback for knee injuries

    This study is testing if real-time feedback on walking can help younger people who had knee surgery recover better and avoid early signs of osteoarthritis.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT05848622

  • Effects of Vibration on Knee Health After ACL Surgery

    This study is testing if adding vibration therapy to regular rehab can help people recovering from ACL surgery have better knee health and lower the chance of future injuries.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina and 1 other locations · NCT04875052

  • Perturbation Training vs Functional Activities after ACL Reconstruction

    This study tests whether perturbation training or task-oriented functional activities help people 18–45 with ACL reconstruction recover better than standard rehab.

    Recruiting Riphah International University · Lahore, Punjab Province · NCT07642752

  • Tracking recovery after arthroscopic shoulder and knee surgeries

    This will follow people having routine arthroscopic shoulder or knee surgery to see if patient characteristics, tear details, or surgical choices predict better recovery and function over two years.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07501013

  • Arthroscopic ACL reconstruction with peroneus longus graft with or without a platelet-rich plasma (PRP) injection

    This test sees if a single 4 ml intra-articular PRP injection given during ACL reconstruction with a peroneus longus graft helps adults (18–50) with isolated ACL tears recover better over 12 months.

    Recruiting Phase 2 Lahore General Hospital · Lahore, Punjab Province · NCT07470359

  • Magic Angle Direction Imaging for ACL tears and meniscus injuries

    This study tries a new low-field MRI technique called Magic Angle Direction Imaging to see if it shows ACL tears and meniscus injuries more clearly in adults scheduled for ligament repair.

    Recruiting at 2 sites Imperial College London · London and 1 other locations · NCT07366619

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.